A 354-patient study on image quality and dose values for thorax images with the DX-D 300 digital radiography system and MUSICA 3 software was carried out at the Institute of Imaging Diagnostics and Therapy (BDI) in Erlangen. Dr. Karina Hofmann-Preiss, summarizes here the details and findings of the study.
Agfa HealthCare
Cardiovascular disease (CVD) is a major cause of death and disability across the world. In recent decades, the battle against CVD has focused on prevention, with the management of lifetime cardiovascular (CV) risk superseding treatment of individual cardiovascular (CV) risk factors. Such a strategy in turn is anchored in two complementary approaches – a population-based one promoting community health (e.g. anti-smoking campaigns, diet and nutritional management) and a clinical approach targeted at high-risk individuals.
Complexity of risk factors
In spite of this, CVD management remains less than optimal – even in countries with advanced and well-funded healthcare systems. In 2007, the authors of an article in the
Recently revised breast cancer screening guidelines from the American Cancer Society (ACS) share some parallels with practices in Europe and are similar to recommendations from other organizations. They have however generated a considerable amount of debate and controversy in the US.
First ACS revisions since 2013
The revised guidelines are the first from the ACS since 2003, and based on a review of 90 breast cancer screening studies and trials that have been completed since 2000. They were published on October 20, 2015, in the
Pandemics – derived from the Greek pandemos (affecting all people) – are not new events, but have occurred sporadically throughout history. These large, infectious epidemics threaten not only global health but can also have catastrophic social, economic and financial effects. Given the periodic nature of pandemics, we know there will be another one sometime, we just don
The conventional method of prostate cancer detection is based on blood tests showing elevated prostate specific antigen (PSA) levels followed by an uncomfortable digital rectal examination (DRE) and a 12-needle biopsy under ultrasound guidance.
Professor Jelle Barentsz, Head of the Prostate MR Reference Centre in Nijmegen, Netherlands, has pioneered a novel approach using magnetic resonance imaging (MRI) to effectively confirm or exclude suspected prostate cancer as well as determine the aggressiveness and spread of the disease, and even treat it in a number of cases. Despite obvious advantages, this approach has yet to gain wider acceptance, not least among radiologists who need to be trained for the procedure. Insurance companies and national health systems also have to be convinced of the benefits of the MRI-based method.
The limitation of the standard PSA test is its low specificity
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
